ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells

Cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) is overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). Interleukin enhancer binding factor 2 (ILF2) has become research hotspot in liver cancer recently. However, it is still unclear whether and how...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Du, Yun Le, Fenyong Sun, Kai Li, Yanfeng Xu
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2019/1575031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110636626804736
author Hui Du
Yun Le
Fenyong Sun
Kai Li
Yanfeng Xu
author_facet Hui Du
Yun Le
Fenyong Sun
Kai Li
Yanfeng Xu
author_sort Hui Du
collection DOAJ
description Cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) is overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). Interleukin enhancer binding factor 2 (ILF2) has become research hotspot in liver cancer recently. However, it is still unclear whether and how CREB and ILF2 interact with each other. And how this interaction exerts its role in occurrence and development of liver cancer is still unclear. Here, we found that ILF2 directly bound with CREB, and this binding was essential for the malignant phenotypes of liver cancer cells. Moreover, we found that ILF2 acted as one of the upstream proteins of CREB and promoted CREB only in the protein level, whereas ILF2 expression was not regulated by CREB. Mechanistically, ILF2 bound to the pKID domain of CREB and stimulated its phosphorylation at Ser133. Taken together, our study finds a novel interaction between CREB and ILF2 in liver cancer, and this interaction might play a role in the diagnosis and remedy of liver cancer.
format Article
id doaj-art-44ac0bd457a547b68e7ebc23ab0c00c7
institution OA Journals
issn 2210-7177
2210-7185
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-44ac0bd457a547b68e7ebc23ab0c00c72025-08-20T02:37:48ZengWileyAnalytical Cellular Pathology2210-71772210-71852019-01-01201910.1155/2019/15750311575031ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer CellsHui Du0Yun Le1Fenyong Sun2Kai Li3Yanfeng Xu4Department of Experiment Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, ChinaDepartment of Pharmacy, Changhai Hospital of Shanghai, 200433, ChinaDepartment of Clinical Laboratory Medicine, Shanghai Tenth People’s Hospital of Tongji University, Shanghai 200072, ChinaPeople’s Hospital of Pudong New District of Shanghai City, No. 490, South Chuanhuan Road, Shanghai 201200, ChinaDepartment of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, ChinaCyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) is overexpressed and has an oncogenic role in hepatocellular carcinoma (HCC). Interleukin enhancer binding factor 2 (ILF2) has become research hotspot in liver cancer recently. However, it is still unclear whether and how CREB and ILF2 interact with each other. And how this interaction exerts its role in occurrence and development of liver cancer is still unclear. Here, we found that ILF2 directly bound with CREB, and this binding was essential for the malignant phenotypes of liver cancer cells. Moreover, we found that ILF2 acted as one of the upstream proteins of CREB and promoted CREB only in the protein level, whereas ILF2 expression was not regulated by CREB. Mechanistically, ILF2 bound to the pKID domain of CREB and stimulated its phosphorylation at Ser133. Taken together, our study finds a novel interaction between CREB and ILF2 in liver cancer, and this interaction might play a role in the diagnosis and remedy of liver cancer.http://dx.doi.org/10.1155/2019/1575031
spellingShingle Hui Du
Yun Le
Fenyong Sun
Kai Li
Yanfeng Xu
ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
Analytical Cellular Pathology
title ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
title_full ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
title_fullStr ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
title_full_unstemmed ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
title_short ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells
title_sort ilf2 directly binds and stabilizes creb to stimulate malignant phenotypes of liver cancer cells
url http://dx.doi.org/10.1155/2019/1575031
work_keys_str_mv AT huidu ilf2directlybindsandstabilizescrebtostimulatemalignantphenotypesoflivercancercells
AT yunle ilf2directlybindsandstabilizescrebtostimulatemalignantphenotypesoflivercancercells
AT fenyongsun ilf2directlybindsandstabilizescrebtostimulatemalignantphenotypesoflivercancercells
AT kaili ilf2directlybindsandstabilizescrebtostimulatemalignantphenotypesoflivercancercells
AT yanfengxu ilf2directlybindsandstabilizescrebtostimulatemalignantphenotypesoflivercancercells